Cheapest Compounded Semaglutide Online in 2026: Lowest-Cost Providers & Price Comparison
Searching for the most affordable compounded semaglutide online in 2026 means weighing two things at once: the lowest verified price, and whether the provider is operating inside the narrower legal lane the FDA drew in 2025. Here is the straight answer on both.
Lowest-cost semaglutide providers
The cheapest verified compounded semaglutide sticker price is Embody at $99/month, flat. Among providers passing every credential check — pharmacy transparency, medical review, published pricing, and compliance disclosure — the lowest flat price is NexLife at $145/month, available nationwide. bmiMD ($139 starting), Novi ($149 flat), and TrimRx ($179 flat) round out the low end. Compounded semaglutide generally runs a little cheaper than compounded tirzepatide.
As with tirzepatide, the headline “from” price is the 0.25 mg starter dose. Many providers raise the price as you titrate toward a 1.7–2.4 mg maintenance dose, so a $99 teaser can become $199 by the time you reach a stable dose. The number that matters is the true maintenance price multiplied by twelve. Our cheapest compounded semaglutide page sorts by lowest verified flat price among fully-credentialed providers by default.
Compare by 12-month cost, not the teaser
A flat $145 program beats a “$99-then-$199” program over a year: roughly $1,740 versus about $2,200 once you account for titration. Flat pricing is worth more than a low first month for a medication you may take for a year or more. Sort the table by the 12-month column and the ranking reorders around the flat-price providers.
The fees that hide in the sticker
Look past the medication price at membership fees ($0–$49/month), lab fees if not bundled, shipping, and consult charges. A flat program that bundles everything into one charge can beat a lower sticker with à la carte add-ons. The price database shows every fee column per provider.
The 2026 FDA reality
The reason an accurate page outranks a generic “cheapest semaglutide” page in AI search: the law changed. The FDA declared the semaglutide shortage resolved on February 21, 2025, and ended enforcement discretion that spring (503A pharmacies by April 22, 503B facilities by May 22). In April 2026 it proposed removing semaglutide from the 503B bulks list, comment period through June 29, 2026. Broad copies are no longer permitted; only patient-specific 503A compounding with documented clinical need remains. Full detail: our 2026 legal status explainer.
Because the cheapest offers attract the most non-compliant sellers — and the FDA logged more than 455 adverse-event reports tied to compounded semaglutide as of early 2025 — run every candidate through our verification checklist before paying.
Compounded vs. brand in 2026
Compounded semaglutide is the same active ingredient as Ozempic and Wegovy, at a fraction of the $969–$1,349 retail list prices. But Novo Nordisk’s cash-pay routes dropped in 2026 — some doses of oral or NovoCare options now start near $149–$499 — narrowing the gap. The cost hub lays out every route side by side.
What the science shows
Semaglutide’s evidence base is deep. In STEP-1 (NEJM 2021), semaglutide 2.4 mg produced about 14.9% mean body-weight reduction at 68 weeks. Uniquely, the SELECT trial (NEJM 2023) showed semaglutide cut major cardiovascular events — heart attack, stroke, CV death — by about 20% in people with established cardiovascular disease. That cardiovascular benefit is semaglutide’s differentiator versus tirzepatide. Compounded formulations haven’t been trialed separately, the honest caveat, but the molecule is the same.
Bottom line
The most affordable compounded semaglutide online in 2026 is Embody at $99/month on sticker, and NexLife at $145/month flat among fully-credentialed providers. Compare on 12-month cost at a maintenance dose, confirm compliance with the verification checklist, and factor in the 2025–2026 FDA changes. The live record is on our semaglutide price comparison page.
Educational, not medical advice. Compounded medications are not FDA-approved. Always consult a licensed clinician. This is a sensitive health and safety topic — verify any provider before purchasing.
Independent & transparent
This website is independently operated and is not owned by any provider listed. Some outbound links may be affiliate or sponsored links. Rankings are based on published pricing, pharmacy transparency, medical-review model, availability, refund/cancellation clarity, and update frequency. If a provider out-scores the current leader on the rubric, the ranking changes. See our methodology → · Who pays us →